RNS Number : 5461E
Stenprop Limited
28 February 2020
 

 

 

 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP    JSE share code: STP

ISIN:  GG00BFWMR296

("Stenprop" or the "Company")

 

TRANSACTION IN OWN SHARES

 

28 February 2020

 

Further to the announcement published on 19 December 2019 informing shareholders that the Company intended to repurchase shares to mitigate the dilutive effect of the scrip dividend election, shareholders are advised that on 27 February 2020, the Company purchased 200,000 ordinary shares at 127 pence per share. These shares will be held as treasury shares.

 

Following the above transaction, the total number of treasury shares held by the Company is 14,742,867 ordinary shares and the total number of shares in issue less shares held in treasury is 284,032,308 ordinary shares. From 27 February 2020, the total number of voting rights in the Company is 284,032,308.

 

 

For further information:

Stenprop Limited                                                                                          44(0)20 3918 6600

Paul Arenson

James Beaumont

Julian Carey

 

Numis Securities Limited (Financial Adviser)                                          44(0)20 7260 1000

Hugh Jonathan

Vicki Paine   

 

Tavistock (PR Adviser)                                                                                 44(0)20 7920 3150

James Whitmore

James Verstringhe

 

Java Capital Trustees and Sponsors Proprietary Limited                      27 (0)11 722 3050

(JSE sponsor)

 

About Stenprop:

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSUWUSRRNUUUAR